Literature DB >> 16783607

MTHFR (C677T and A1298C) polymorphisms and risk of sporadic distal colorectal adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom).

Panagiota N Mitrou1, Mark A Watson, Alexandre S Loktionov, Christopher Cardwell, Marc J Gunter, Wendy S Atkin, Christopher P Macklin, Tom Cecil, Timothy D Bishop, John Primrose, Sheila A Bingham.   

Abstract

OBJECTIVE: The purpose of this study was to further evaluate the role of low activity MTHFR variants as well as to explore interactive effects between alcoholic drink consumption and MTHFR variants and risk of distal colorectal adenomatous polyps.
METHODS: We examined the relationship between MTHFR C677T and A1298C gene polymorphisms and risk of distal adenomas in one of the largest case control studies of 946 polyp-free controls and 894 cases, all participants of the UK Flexible Sigmoidoscopy Screening Trial (UKFSS).
RESULTS: Investigation of the effect of the MTHFR C677T polymorphism in this large UKFSS study revealed no overall association on adenoma risk (P>0.05). However the MTHFR 1298C allele was linked, for the first time, to high risk adenomas, although in males only (odds ratio (OR) for A/C+C/C compared with A/A 1.55; 95% confidence interval (CI), 1.08-2.22; P=0.018).
CONCLUSIONS: In this, the largest study of these polymorphisms in relation to colorectal adenoma, there was no evidence for an interaction with alcohol in combination with the variant forms of MTHFR (P>0.05).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783607     DOI: 10.1007/s10552-006-0016-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  6 in total

1.  Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essential hypertension.

Authors:  Weijuan Cai; Liang Yin; Fang Yang; Lei Zhang; Jiang Cheng
Journal:  Biomed Rep       Date:  2014-09-05

2.  Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis.

Authors:  Yan Huang; Shizhong Han; Yao Li; Yumin Mao; Yi Xie
Journal:  J Hum Genet       Date:  2006-11-07       Impact factor: 3.172

Review 3.  Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review.

Authors:  E Taioli; M A Garza; Y O Ahn; D T Bishop; J Bost; B Budai; K Chen; F Gemignani; T Keku; C S P Lima; L Le Marchand; K Matsuo; V Moreno; J Plaschke; M Pufulete; S B Thomas; G Toffoli; C R Wolf; C G Moore; J Little
Journal:  Am J Epidemiol       Date:  2009-10-21       Impact factor: 4.897

4.  MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.

Authors:  Stuart G Reeves; Cliff Meldrum; Claire Groombridge; Allan D Spigelman; Janina Suchy; Grzegorz Kurzawski; Jan Lubinski; Patrick McElduff; Rodney J Scott
Journal:  Eur J Hum Genet       Date:  2009-01-21       Impact factor: 4.246

5.  Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study.

Authors:  A Joan Levine; Won Lee; Jane C Figueiredo; David V Conti; David J Vandenberg; Brian D Davis; Christopher K Edlund; Susanne M Henning; David Heber; Mariana C Stern; Robert W Haile
Journal:  Cancer Causes Control       Date:  2011-01-28       Impact factor: 2.506

6.  Genetic impact of methylenetetrahydrofolate reductase (MTHFR) polymorphism on the susceptibility to colorectal polyps: a meta-analysis.

Authors:  Manyi Sun; Jin Zhong; Li Zhang; Songli Shi
Journal:  BMC Med Genet       Date:  2019-05-30       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.